Headlines about Medidata Solutions (NASDAQ:MDSO) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Medidata Solutions earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.1679134563645 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
A number of equities research analysts have recently weighed in on the company. Zacks Investment Research upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, September 20th. Royal Bank Of Canada assumed coverage on Medidata Solutions in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $82.00 target price for the company. KeyCorp restated a “buy” rating and set a $86.00 target price on shares of Medidata Solutions in a research report on Sunday, September 17th. Jefferies Group LLC restated a “hold” rating and set a $78.00 target price on shares of Medidata Solutions in a research report on Tuesday, August 22nd. Finally, BidaskClub downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $84.64.
Shares of Medidata Solutions (NASDAQ MDSO) opened at 80.30 on Wednesday. The firm has a 50 day moving average price of $76.67 and a 200 day moving average price of $73.20. Medidata Solutions has a one year low of $46.10 and a one year high of $85.92. The company has a market capitalization of $4.55 billion, a P/E ratio of 129.73 and a beta of 1.77.
Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.03. The firm had revenue of $137.41 million for the quarter, compared to analysts’ expectations of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The business’s quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.24 earnings per share. On average, equities research analysts predict that Medidata Solutions will post $1.29 EPS for the current fiscal year.
In related news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $74.53, for a total value of $372,650.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 5.80% of the stock is owned by corporate insiders.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with our FREE daily email newsletter.